The DOI matches its Crossref record; 178 of the 178 references it cites were found in a registry or an index.
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
Open accessAbstract
The intracellular sensing protein termed NLRP3 (for NACHT, LRR, and PYD domains-containing protein 3) forms a macromolecular structure called the NLRP3 inflammasome. The NLRP3 inflammasome plays a major role in inflammation, particularly in the production of IL (interleukin)-1β. IL-1β is the most studied of the IL-1 family of cytokines, including 11 members, among which are IL-1α and IL-18. Here, we summarize preclinical and clinical findings supporting the key pathogenetic role of the NLRP3 inflammasome and IL-1 cytokines in the formation, progression, and complications of atherosclerosis, in ischemic (acute myocardial infarction), and nonischemic injury to the myocardium (myocarditis) and the progression to heart failure. We also review the clinically available IL-1 inhibitors, although not currently approved for cardiovascular indications, and discuss other IL-1 inhibitors, not currently approved, as well as oral NLRP3 inflammasome inhibitors currently in clinical development. Canakinumab, IL-1β antibody, prevented the recurrence of ischemic events in patients with prior acute myocardial infarction in a large phase III clinical trial, including 10 061 patients world-wide. Phase II clinical trials show promising data with anakinra, recombinant IL-1 receptor antagonist, in patients with ST-segment–elevation acute myocardial infarction or heart failure with reduced ejection fraction. Anakinra also improved outcomes in patients with pericarditis, and it is now considered standard of care as second-line treatment for patients with recurrent/refractory pericarditis. Rilonacept, a soluble IL-1 receptor chimeric fusion protein neutralizing IL-1α and IL-1β, has also shown promising results in a phase II study in recurrent/refractory pericarditis. In conclusion, there is overwhelming evidence linking the NLRP3 inflammasome and the IL-1 cytokines with the pathogenesis of cardiovascular diseases. The future will likely include targeted inhibitors to block the IL-1 isoforms, and possibly oral NLRP3 inflammasome inhibitors, across a wide spectrum of cardiovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yin, H., Li, P., Hu, F., Wang, Y., Chai, X., & Zhang, Y. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2051 · Cited by 42
RetractedAtherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Libby, P., Buring, J. E., Badimon, L., Hansson, G. K., Deanfield, J., Bittencourt, M. S., Tokgözoğlu, L., & Lewis, E. F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0106-z · Cited by 3,211
Efficacy and safety of low-dose colchicine after myocardial infarction
Tardif, J.-C., Kouz, S., Waters, D. D., Bertrand, O. F., Diaz, R., Maggioni, A. P., Pinto, F. J., Ibrahim, R., Gamra, H., Kiwan, G. S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1912388 · Cited by 3,159
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248 · cited 1×
“(2) Over time, the accumulation of lipids, including cholesterol, and inflammatory cells leads to production of cytokines, including IL-1α, NLRP3 (NACHT, LRR, and PYD domains-containing protein 3) inflammasome activation, and production of inflammasome dependent cytokines IL-1β and IL-18.”
BackgroundSelf-citationOverview of the IL ‐1 family in innate inflammation and acquired immunity
Dinarello, C. A. (2018) · Immunological Reviews · doi:10.1111/imr.12621 · Cited by 1,866
Self-citationAgostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Dinarello, C. A., Simon, A., & van der Meer, J. W. M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3800 · Cited by 1,768
Self-citationThe inflammatory response in myocardial injury, repair, and remodelling
Frangogiannis, N. G. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.28 · Cited by 1,738
Hofstra, L., Tordoir, J. H. M., Kitslaar, P. J. E. H. M., Hoeks, A. P. G., & Daemen, M. J. A. P. (1996) · Circulation · doi:10.1161/01.cir.94.6.1283 · Cited by 1,603
Ridker, P. M., MacFadyen, J. G., Thuren, T., Everett, B. M., Libby, P., Glynn, R. J., Ridker, P., Lorenzatti, A., Krum, H., Varigos, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32247-x · Cited by 1,344
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Ridker, P. M., Everett, B. M., Pradhan, A., MacFadyen, J. G., Solomon, D. H., Zaharris, E., Mam, V., Hasan, A., Rosenberg, Y., Iturriaga, E., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1809798 · Cited by 1,317
Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
Yang, Y., Wang, H., Kouadir, M., Song, H., & Shi, F. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1413-8 · Cited by 1,269
Anderson, J. L., & Morrow, D. A. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1606915 · Cited by 1,115
Bevilacqua, M. P., Pober, J. S., Wheeler, M. E., Cotran, R. S., & Gimbrone, M. A. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112200 · Cited by 1,104
Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
Nidorf, S. M., Eikelboom, J. W., Budgeon, C. A., & Thompson, P. L. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.10.027 · Cited by 1,054
IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system
Sanada, S., Hakuno, D., Higgins, L. J., Schreiter, E. R., McKenzie, A. N. J., & Lee, R. T. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30634 · Cited by 1,044
Rajamäki, K., Lappalainen, J., Öörni, K., Välimäki, E., Matikainen, S., Kovanen, P. T., & Eklund, K. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011765 · Cited by 1,039
Deswal, A., Petersen, N. J., Feldman, A. M., Young, J. B., White, B. G., & Mann, D. L. (2001) · Circulation · doi:10.1161/01.cir.103.16.2055 · Cited by 1,012
Ridker, P. M. (2016) · Circulation Research · doi:10.1161/circresaha.115.306656 · Cited by 1,002
Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4
Colotta, F., Re, F., Muzio, M., Bertini, R., Polentarutti, N., Sironi, M., Giri, J. G., Dower, S. K., Sims, J. E., & Mantovani, A. (1993) · Science · doi:10.1126/science.8332913 · Cited by 980
Colchicine—Update on mechanisms of action and therapeutic uses
Leung, Y. Y., Yao Hui, L. L., & Kraus, V. B. (2015) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2015.06.013 · Cited by 950
Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Cotran, R. S., & Gimbrone, M. A. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.2.618 · Cited by 935
Ridker, P. M., MacFadyen, J. G., Everett, B. M., Libby, P., Thuren, T., Glynn, R. J., Ridker, P. M., MacFadyen, J. G., Everett, B. M., Libby, P., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32814-3 · Cited by 919
Kawaguchi, M., Takahashi, M., Hata, T., Kashima, Y., Usui, F., Morimoto, H., Izawa, A., Takahashi, Y., Masumoto, J., Koyama, J., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.982777 · Cited by 884
Chen, C.-J., Kono, H., Golenbock, D., Reed, G., Akira, S., & Rock, K. L. (2007) · Nature Medicine · doi:10.1038/nm1603 · Cited by 876
Shakoory, B., Carcillo, J. A., Chatham, W. W., Amdur, R. L., Zhao, H., Dinarello, C. A., Cron, R. Q., & Opal, S. M. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001402 · Cited by 867
Self-citationOpal, S. M., Fisher, C. J., Dhainaut, J.-F. A., Vincent, J.-L., Brase, R., Lowry, S. F., Sadoff, J. C., Slotman, G. J., Levy, H., Balk, R. A., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00010 · Cited by 865
Netea, M. G., Nold-Petry, C. A., Nold, M. F., Joosten, L. A. B., Opitz, B., van der Meer, J. H. M., van de Veerdonk, F. L., Ferwerda, G., Heinhuis, B., Devesa, I., et al. (2009) · Blood · doi:10.1182/blood-2008-03-146720 · Cited by 792
Self-citationKumar, A., Thota, V, Dee, L., Olson, J., Uretz, E., & Parrillo, J. E. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.949 · Cited by 791
Interleukin-18 Binding Protein
Novick, D., Kim, S.-H., Fantuzzi, G., Reznikov, L. L., Dinarello, C. A., & Rubinstein, M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80013-8 · Cited by 779
Self-citationVasan, R. S., Sullivan, L. M., Roubenoff, R., Dinarello, C. A., Harris, T., Benjamin, E. J., Sawyer, D. B., Levy, D., Wilson, P. W. F., & D’Agostino, R. B. (2003) · Circulation · doi:10.1161/01.cir.0000057810.48709.f6 · Cited by 746
Self-citationThe NLRP3 inflammasome in acute myocardial infarction
Toldo, S., & Abbate, A. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.161 · Cited by 665
Self-citationAnti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure
Everett, B. M., Cornel, J. H., Lainscak, M., Anker, S. D., Abbate, A., Thuren, T., Libby, P., Glynn, R. J., & Ridker, P. M. (2019) · Circulation · doi:10.1161/circulationaha.118.038010 · Cited by 658
Self-citationC Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC) (2011) · BMJ · doi:10.1136/bmj.d548 · Cited by 642
IL-33 reduces the development of atherosclerosis
Miller, A. M., Xu, D., Asquith, D. L., Denby, L., Li, Y., Sattar, N., Baker, A. H., McInnes, I. B., & Liew, F. Y. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071868 · Cited by 642
Mezzaroma, E., Toldo, S., Farkas, D., Seropian, I. M., Van Tassell, B. W., Salloum, F. N., Kannan, H. R., Menna, A. C., Voelkel, N. F., & Abbate, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108586108 · Cited by 629
Self-citationImazio, M., Bobbio, M., Cecchi, E., Demarie, D., Demichelis, B., Pomari, F., Moratti, M., Gaschino, G., Giammaria, M., Ghisio, A., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.542738 · Cited by 614
A Randomized Trial of Colchicine for Acute Pericarditis
Imazio, M., Brucato, A., Cemin, R., Ferrua, S., Maggiolini, S., Beqaraj, F., Demarie, D., Forno, D., Ferro, S., Maestroni, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208536 · Cited by 611
Birnie, D. H., Nery, P. B., Ha, A. C., & Beanlands, R. S. B. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.605 · Cited by 569
Interleukin-18 Is a Strong Predictor of Cardiovascular Death in Stable and Unstable Angina
Blankenberg, S., Tiret, L., Bickel, C., Peetz, D., Cambien, F., Meyer, J., & Rupprecht, H. J. (2002) · Circulation · doi:10.1161/01.cir.0000020546.30940.92 · Cited by 568
Ridker, P. M., Libby, P., MacFadyen, J. G., Thuren, T., Ballantyne, C., Fonseca, F., Koenig, W., Shimokawa, H., Everett, B. M., & Glynn, R. J. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy310 · Cited by 544
TESTA, M., YEH, M., LEE, P., BERMAN, J. W., LEJEMTEL, T. H., FANELLI, R., & LOPERFIDO, F. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00268-9 · Cited by 540
Ridker, P. M., Howard, C. P., Walter, V., Everett, B., Libby, P., Hensen, J., & Thuren, T. (2012) · Circulation · doi:10.1161/circulationaha.112.122556 · Cited by 530
Sandanger, Ø., Ranheim, T., Vinge, L. E., Bliksøen, M., Alfsnes, K., Finsen, A. V., Dahl, C. P., Askevold, E. T., Florholmen, G., Christensen, G., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt091 · Cited by 524
Libby, P., Ordovás, J. M., Auger, K. R., Robbins, A. H., Birinyi, L. K., & Dinarello, C. A. (1986) · PubMed Central · Cited by 494
Self-citationIdentification of a membrane-associated interleukin 1 in macrophages.
Kurt-Jones, E. A., Beller, D. I., Mizel, S. B., & Unanue, E. R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.4.1204 · Cited by 493
Host and Environmental Factors Influencing Individual Human Cytokine Responses
ter Horst, R., Jaeger, M., Smeekens, S. P., Oosting, M., Swertz, M. A., Li, Y., Kumar, V., Diavatopoulos, D. A., Jansen, A. F. M., Lemmers, H., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.018 · Cited by 453
Self-citationImazio, M., Bobbio, M., Cecchi, E., Demarie, D., Pomari, F., Moratti, M., Ghisio, A., Belli, R., & Trinchero, R. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.17.1987 · Cited by 424
Abbate, A., Kontos, M. C., Grizzard, J. D., Biondi-Zoccai, G. G. L., Van Tassell, B. W., Robati, R., Roach, L. M., Arena, R. A., Roberts, C. S., Varma, A., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.12.059 · Cited by 415
Self-citationMallat, Z., Corbaz, A., Scoazec, A., Graber, P., Alouani, S., Esposito, B., Humbert, Y., Chvatchko, Y., & Tedgui, A. (2001) · Circulation Research · doi:10.1161/hh1901.098735 · Cited by 407
Imazio, M., Belli, R., Brucato, A., Cemin, R., Ferrua, S., Beqaraj, F., Demarie, D., Ferro, S., Forno, D., Maestroni, S., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62709-9 · Cited by 406
Brucato, A., Imazio, M., Gattorno, M., Lazaros, G., Maestroni, S., Carraro, M., Finetti, M., Cumetti, D., Carobbio, A., Ruperto, N., et al. (2016) · JAMA · doi:10.1001/jama.2016.15826 · Cited by 401
Management of Acute and Recurrent Pericarditis
Chiabrando, J. G., Bonaventura, A., Vecchié, A., Wohlford, G. F., Mauro, A. G., Jordan, J. H., Grizzard, J. D., Montecucco, F., Berrocal, D. H., Brucato, A., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.021 · Cited by 396
Self-citationAbbate, A., Van Tassell, B. W., Biondi-Zoccai, G., Kontos, M. C., Grizzard, J. D., Spillman, D. W., Oddi, C., Roberts, C. S., Melchior, R. D., Mueller, G. H., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.01.287 · Cited by 393
Self-citationvan de Veerdonk, F. L., Stoeckman, A. K., Wu, G., Boeckermann, A. N., Azam, T., Netea, M. G., Joosten, L. A. B., van der Meer, J. W. M., Hao, R., Kalabokis, V., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121534109 · Cited by 380
Self-citationLoppnow, H., & Libby, P. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114498 · Cited by 375
Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice
Elhage, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00343-2 · Cited by 373
Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury
Toldo, S., Mauro, A. G., Cutter, Z., & Abbate, A. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00158.2018 · Cited by 369
Self-citationThe IL-1 family of cytokines and receptors in rheumatic diseases
Dinarello, C. A. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0277-8 · Cited by 366
Self-citationSeki, K., Sanada, S., Kudinova, A. Y., Steinhauser, M. L., Handa, V., Gannon;, J., & Lee, R. T. (2009) · Circulation: Heart Failure · doi:10.1161/circheartfailure.109.873240 · Cited by 365
Abbate, A., Salloum, F. N., Vecile, E., Das, A., Hoke, N. N., Straino, S., Biondi-Zoccai, G. G. L., Houser, J.-E., Qureshi, I. Z., Ownby, E. D., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.740233 · Cited by 360
Self-citationThe Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy
Heymans, S., Eriksson, U., Lehtonen, J., & Cooper, L. T. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.937 · Cited by 359
Morton, A. C., Rothman, A. M. K., Greenwood, J. P., Gunn, J., Chase, A., Clarke, B., Hall, A. S., Fox, K., Foley, C., Banya, W., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu272 · Cited by 353
Rapid responses to anakinra in patients with refractory adult‐onset Still's disease
Fitzgerald, A. A., LeClercq, S. A., Yan, A., Homik, J. E., & Dinarello, C. A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21061 · Cited by 350
Self-citationvan der Heijden, T., Kritikou, E., Venema, W., van Duijn, J., van Santbrink, P. J., Slütter, B., Foks, A. C., Bot, I., & Kuiper, J. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.309575 · Cited by 348
Fan, J., Kitajima, S., Watanabe, T., Xu, J., Zhang, J., Liu, E., & Chen, Y. E. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.09.009 · Cited by 333
van Hout, G. P. J., Bosch, L., Ellenbroek, G. H. J. M., de Haan, J. J., van Solinge, W. W., Cooper, M. A., Arslan, F., de Jager, S. C. A., Robertson, A. A. B., Pasterkamp, G., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw247 · Cited by 331
Shao, W., Yeretssian, G., Doiron, K., Hussain, S. N., & Saleh, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708182200 · Cited by 322
Liu, Y., Lian, K., Zhang, L., Wang, R., Yi, F., Gao, C., Xin, C., Zhu, D., Li, Y., Yan, W., et al. (2014) · Basic Research in Cardiology · doi:10.1007/s00395-014-0415-z · Cited by 321
The Biology of ST2: The International ST2 Consensus Panel
Pascual-Figal, D. A., & Januzzi, J. L. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.01.034 · Cited by 319
Arterial Inflammation in Mice Lacking the Interleukin 1 Receptor Antagonist Gene
Nicklin, M. J. H., Hughes, D. E., Barton, J. L., Ure, J. M., & Duff, G. W. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.303 · Cited by 317
In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes
Lachmann, H. J., Lowe, P., Felix, S. D., Rordorf, C., Leslie, K., Madhoo, S., Wittkowski, H., Bek, S., Hartmann, N., Bosset, S., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082481 · Cited by 312
Pomerantz, B. J., Reznikov, L. L., Harken, A. H., & Dinarello, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041611398 · Cited by 310
Self-citationIkonomidis, I., Lekakis, J. P., Nikolaou, M., Paraskevaidis, I., Andreadou, I., Kaplanoglou, T., Katsimbri, P., Skarantavos, G., Soucacos, P. N., & Kremastinos, D. T. (2008) · Circulation · doi:10.1161/circulationaha.107.731877 · Cited by 307
Targeting Interleukin-1 in Heart Disease
Van Tassell, B. W., Toldo, S., Mezzaroma, E., & Abbate, A. (2013) · Circulation · doi:10.1161/circulationaha.113.003199 · Cited by 302
Self-citationAbbate, A., Trankle, C. R., Buckley, L. F., Lipinski, M. J., Appleton, D., Kadariya, D., Canada, J. M., Carbone, S., Roberts, C. S., Abouzaki, N., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014941 · Cited by 300
Self-citationSeropian, I. M., Toldo, S., Van Tassell, B. W., & Abbate, A. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.014 · Cited by 296
Self-citationEffects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
Cavelti-Weder, C., Babians-Brunner, A., Keller, C., Stahel, M. A., Kurz-Levin, M., Zayed, H., Solinger, A. M., Mandrup-Poulsen, T., Dinarello, C. A., & Donath, M. Y. (2012) · Diabetes Care · doi:10.2337/dc11-2219 · Cited by 294
Self-citationShimokawa, H., Ito, A., Fukumoto, Y., Kadokami, T., Nakaike, R., Sakata, M., Takayanagi, T., Egashira, K., & Takeshita, A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118476 · Cited by 292
From Focal Lipid Storage to Systemic Inflammation
Libby, P., & Hansson, G. K. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.061 · Cited by 288
Van Tassell, B. W., Arena, R., Biondi-Zoccai, G., McNair Canada, J., Oddi, C., Abouzaki, N. A., Jahangiri, A., Falcao, R. A., Kontos, M. C., Shah, K. B., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.08.047 · Cited by 281
Self-citationAnti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction: A Pilot Study
Deftereos, S., Giannopoulos, G., Angelidis, C., Alexopoulos, N., Filippatos, G., Papoutsidakis, N., Sianos, G., Goudevenos, J., Alexopoulos, D., Pyrgakis, V., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.017611 · Cited by 279
A NOVEL IL-18BP ELISA SHOWS ELEVATED SERUM IL-18BP IN SEPSIS AND EXTENSIVE DECREASE OF FREE IL-18
Novick, D., Schwartsburd, B., Pinkus, R., Suissa, D., Belzer, I., Sthoeger, Z., Keane, W. F., Chvatchko, Y., Kim, S.-H., Fantuzzi, G., et al. (2001) · Cytokine · doi:10.1006/cyto.2001.0914 · Cited by 277
Self-citationMarchetti, C., Chojnacki, J., Toldo, S., Mezzaroma, E., Tranchida, N., Rose, S. W., Federici, M., Van Tassell, B. W., Zhang, S., & Abbate, A. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000053 · Cited by 264
Self-citationInterleukin-1β has atheroprotective effects in advanced atherosclerotic lesions of mice
Gomez, D., Baylis, R. A., Durgin, B. G., Newman, A. A. C., Alencar, G. F., Mahan, S., St. Hilaire, C., Müller, W., Waisman, A., Francis, S. E., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0124-5 · Cited by 256
Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction
Sager, H. B., Heidt, T., Hulsmans, M., Dutta, P., Courties, G., Sebas, M., Wojtkiewicz, G. R., Tricot, B., Iwamoto, Y., Sun, Y., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.016160 · Cited by 253
Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome
Menu, P., Pellegrin, M., Aubert, J.-F., Bouzourene, K., Tardivel, A., Mazzolai, L., & Tschopp, J. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.18 · Cited by 251
Van Tassell, B. W., Canada, J., Carbone, S., Trankle, C., Buckley, L., Oddi Erdle, C., Abouzaki, N. A., Dixon, D., Kadariya, D., Christopher, S., et al. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.117.004373 · Cited by 245
Self-citationToldo, S., Marchetti, C., Mauro, A. G., Chojnacki, J., Mezzaroma, E., Carbone, S., Zhang, S., Van Tassell, B., Salloum, F. N., & Abbate, A. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.02.043 · Cited by 242
Self-citationRidker, P. M., MacFadyen, J. G., Thuren, T., & Libby, P. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz542 · Cited by 239
Response to local inflammation of IL-1 beta-converting enzyme- deficient mice
Fantuzzi, G., Ku, G., Harding, M. W., Livingston, D. J., Sipe, J. D., Kuida, K., Flavell, R. A., & Dinarello, C. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.4.1818 · Cited by 232
Self-citationVan Tassell, B. W., Arena, R. A., Toldo, S., Mezzaroma, E., Azam, T., Seropian, I. M., Shah, K., Canada, J., Voelkel, N. F., Dinarello, C. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033438 · Cited by 232
Self-citationInterleukin-1 Receptor Antagonist Expression in Human Endothelial Cells and Atherosclerosis
Dewberry, R., Holden, H., Crossman, D., & Francis, S. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.11.2394 · Cited by 227
Bhaskar, V., Yin, J., Mirza, A. M., Phan, D., Vanegas, S., Issafras, H., Michelson, K., Hunter, J. J., & Kantak, S. S. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.02.026 · Cited by 225
Kim, B., Lee, Y., Kim, E., Kwak, A., Ryoo, S., Bae, S. H., Azam, T., Kim, S., & Dinarello, C. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00391 · Cited by 218
Self-citationSuppression of innate inflammation and immunity by interleukin‐37
Dinarello, C. A., Nold‐Petry, C., Nold, M., Fujita, M., Li, S., Kim, S., & Bufler, P. (2016) · European Journal of Immunology · doi:10.1002/eji.201545828 · Cited by 218
Self-citationAlexander, M. R., Moehle, C. W., Johnson, J. L., Yang, Z., Lee, J. K., Jackson, C. L., & Owens, G. K. (2012) · Journal of Clinical Investigation · doi:10.1172/jci43713 · Cited by 217
IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction: Results From DHART2
Van Tassell, B. W., Trankle, C. R., Canada, J. M., Carbone, S., Buckley, L., Kadariya, D., Del Buono, M. G., Billingsley, H., Wohlford, G., Viscusi, M., et al. (2018) · Circulation: Heart Failure · doi:10.1161/circheartfailure.118.005036 · Cited by 213
Self-citationElhage, R., Maret, A., Pieraggi, M.-T., Thiers, J. C., Arnal, J. F., & Bayard, F. (1998) · Circulation · doi:10.1161/01.cir.97.3.242 · Cited by 209
Interleukin-1 blockade in cardiovascular diseases: a clinical update
Buckley, L. F., & Abbate, A. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy128 · Cited by 194
Self-citationNLRP3 Inflammasomes Show High Expression in Aorta of Patients with Atherosclerosis
Zheng, F., Xing, S., Gong, Z., & Xing, Q. (2013) · Heart, Lung and Circulation · doi:10.1016/j.hlc.2013.01.012 · Cited by 190
Imazio, M., Andreis, A., De Ferrari, G. M., Cremer, P. C., Mardigyan, V., Maestroni, S., Luis, S. A., Lopalco, G., Emmi, G., Lotan, D., et al. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487319879534 · Cited by 190
Usui, F., Shirasuna, K., Kimura, H., Tatsumi, K., Kawashima, A., Karasawa, T., Hida, S., Sagara, J., Taniguchi, S., & Takahashi, M. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.058 · Cited by 184
IL-33 Reduces Macrophage Foam Cell Formation
McLaren, J. E., Michael, D. R., Salter, R. C., Ashlin, T. G., Calder, C. J., Miller, A. M., Liew, F. Y., & Ramji, D. P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000520 · Cited by 184
Fuse, K., Chan, G., Liu, Y., Gudgeon, P., Husain, M., Chen, M., Yeh, W.-C., Akira, S., & Liu, P. P. (2005) · Circulation · doi:10.1161/circulationaha.105.536433 · Cited by 181
Johnston, W. F., Salmon, M., Su, G., Lu, G., Stone, M. L., Zhao, Y., Owens, G. K., Upchurch, G. R., & Ailawadi, G. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300432 · Cited by 170
Anti-Inflammatory Treatment With Colchicine in Stable Chronic Heart Failure
Deftereos, S., Giannopoulos, G., Panagopoulou, V., Bouras, G., Raisakis, K., Kossyvakis, C., Karageorgiou, S., Papadimitriou, C., Vastaki, M., Kaoukis, A., et al. (2014) · JACC: Heart Failure · doi:10.1016/j.jchf.2013.11.006 · Cited by 169
The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications
Herder, C., Dalmas, E., Böni-Schnetzler, M., & Donath, M. Y. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.08.001 · Cited by 168
Isoda, K., Sawada, S., Ishigami, N., Matsuki, T., Miyazaki, K., Kusuhara, M., Iwakura, Y., & Ohsuzu, F. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000127025.48140.a3 · Cited by 164
Hickish, T., Andre, T., Wyrwicz, L., Saunders, M., Sarosiek, T., Kocsis, J., Nemecek, R., Rogowski, W., Lesniewski-Kmak, K., Petruzelka, L., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30006-2 · Cited by 164
IL-37 Inhibits Inflammasome Activation and Disease Severity in Murine Aspergillosis
Moretti, S., Bozza, S., Oikonomou, V., Renga, G., Casagrande, A., Iannitti, R. G., Puccetti, M., Garlanda, C., Kim, S., Li, S., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004462 · Cited by 161
Self-citationAbbate, A., Kontos, M. C., Abouzaki, N. A., Melchior, R. D., Thomas, C., Van Tassell, B. W., Oddi, C., Carbone, S., Trankle, C. R., Roberts, C. S., et al. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.11.003 · Cited by 160
Self-citationMyocardial pressure overload induces systemic inflammation through endothelial cell IL-33
Chen, W.-Y., Hong, J., Gannon, J., Kakkar, R., & Lee, R. T. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424236112 · Cited by 158
Mastrocola, R., Penna, C., Tullio, F., Femminò, S., Nigro, D., Chiazza, F., Serpe, L., Collotta, D., Alloatti, G., Cocco, M., et al. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/5271251 · Cited by 158
Toldo, S. A., Mauro, A. G., Cutter, Z., Tassell, B. W. V., Mezzaroma, E., Buono, M. G. D., Prestamburgo, A., Potere, N., & Abbate, A. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000658 · Cited by 158
Self-citationInnate immunity as a target for acute cardioprotection
Zuurbier, C. J., Abbate, A., Cabrera-Fuentes, H. A., Cohen, M. V., Collino, M., de Kleijn, D. P. V., Downey, J. M., Pagliaro, P., Preissner, K. T., Takahashi, M., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy304 · Cited by 156
Self-citationZhang, J., Rudemiller, N. P., Patel, M. B., Karlovich, N. S., Wu, M., McDonough, A. A., Griffiths, R., Sparks, M. A., Jeffs, A. D., & Crowley, S. D. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.11.013 · Cited by 153
Fujisue, K., Sugamura, K., Kurokawa, H., Matsubara, J., Ishii, M., Izumiya, Y., Kaikita, K., & Sugiyama, S. (2017) · Circulation Journal · doi:10.1253/circj.cj-16-0949 · Cited by 148
Devlin, C. M., Kuriakose, G., Hirsch, E., & Tabas, I. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092324399 · Cited by 147
Caspase-1 Deficiency Decreases Atherosclerosis in Apolipoprotein E-Null Mice
Gage, J., Hasu, M., Thabet, M., & Whitman, S. C. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.10.013 · Cited by 146
Tassell, B. W. V., Abouzaki, N. A., Oddi, C., Carbone, S., Trankle, C. R., Melchior, R. D., Turlington, J., Thurber, C. J., Christopher, S., Dixon, D. L., et al. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000378 · Cited by 143
Self-citationInterleukin-18 mediates interleukin-1-induced cardiac dysfunction
Toldo, S. A., Mezzaroma, E., O’Brien, L. C., Marchetti, C., Seropian, I. M., Voelkel, N. F., Tassell, B. W. V., Dinarello, C. A., & Abbate, A. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00795.2013 · Cited by 141
Self-citationFulp, J., Liu, H., Toldo, S. A., Jiang, Y., Boice, A., Guo, C., Li, X., Rolfe, A., Sun, D., Abbate, A., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00733 · Cited by 138
Self-citationInterleukin-1 Regulates Multiple Atherogenic Mechanisms in Response to Fat Feeding
Chamberlain, J., Francis, S., Brookes, Z. L. S., Shaw, G., Graham, D., Alp, N. J., Dower, S., & Crossman, D. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005073 · Cited by 132
Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis
Vromman, A., Ruvkun, V., Shvartz, E., Wojtkiewicz, G. R., Masson, G. S., Tesmenitsky, Y., Folco, E. J. E., Gram, H., Nahrendorf, M., Świrski, F. K., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz008 · Cited by 132
Interleukin-1β induces a reversible cardiomyopathy in the mouse
Tassell, B. W. V., Seropian, I. M., Toldo, S. A., Mezzaroma, E., & Abbate, A. (2013) · Inflammation Research · doi:10.1007/s00011-013-0625-0 · Cited by 128
Self-citationST2 Testing for Chronic Heart Failure Therapy Monitoring: The International ST2 Consensus Panel
Januzzi, J. L., Pascual-Figal, D. A., & Daniels, L. B. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.01.044 · Cited by 127
Herder, C., Gala, T. D. L. H., Carstensen‐Kirberg, M., Huth, C., Zierer, A., Wahl, S., Sudduth-Klinger, J., Kuulasmaa, K., Peretz, D., Ligthart, S., et al. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309307 · Cited by 122
Toldo, S. A., Mezzaroma, E., Tassell, B. W. V., Farkas, D., Marchetti, C., Voelkel, N. F., & Abbate, A. (2012) · Experimental Physiology · doi:10.1113/expphysiol.2012.069831 · Cited by 120
Self-citationChamberlain, J., EVANS, D. B., King, A. R., Dewberry, R. M., Dower, S., Crossman, D. C., & Francis, S. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051054 · Cited by 117
Interleukin-37 ameliorates myocardial ischaemia/reperfusion injury in mice
Wu, B., Meng, K., Ji, Q., Cheng, M., Yu, K., Zhao, X., Tony, H., Liu, Y., Zhou, Y., Chang, C. C., et al. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12284 · Cited by 116
Qingchun, Z., Song, R., Fullerton, D. A., Ao, L., Zhai, Y., Li, S., Ballak, D. B., Cleveland, J. C., Reece, T. B., McKinsey, T. A., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619667114 · Cited by 116
Self-citationInvolvement of NLRP3 inflammasome in CVB3-induced viral myocarditis
Wang, Y., Gao, B., & Xiong, S. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00441.2014 · Cited by 115
Abbate, A., Tassell, B. W. V., Seropian, I. M., Toldo, S. A., Robati, R., Varma, A., Salloum, F. N., Smithson, L. A., & Dinarello, C. A. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq017 · Cited by 113
Self-citationMembrane IL-1: IL-1 alpha precursor binds to the plasma membrane via a lectin-like interaction.
Brody, D. T., & Durum, S. K. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.4.1183 · Cited by 111
Biology of IL ‐38 and its role in disease
van de Veerdonk, F. L., de Graaf, D. M., Joosten, L. A. B., & Dinarello, C. A. (2017) · Immunological Reviews · doi:10.1111/imr.12612 · Cited by 98
Self-citationTreating Life-Threatening Myocarditis by Blocking Interleukin-1*
Cavalli, G., Pappalardo, F., Mangieri, A., Dinarello, C. A., Dagna, L., & Tresoldi, M. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001654 · Cited by 96
Self-citationAltaf, A., Qu, P., Zhao, Y., Kuang, P., Wang, H., Lou, D., Niu, N., & Yuan, D. (2015) · Heart and Vessels · doi:10.1007/s00380-015-0723-8 · Cited by 95
Targeting Interleukin-1 in Heart Failure and Inflammatory Heart Disease
Tassell, B. W. V., Raleigh, J. M. V., & Abbate, A. (2014) · Current Heart Failure Reports · doi:10.1007/s11897-014-0231-7 · Cited by 91
Self-citationHoffman, H. M., Gregory, S. G., Mueller, J. L., Tresierras, M., Broide, D. H., Wanderer, A. A., & Kolodner, R. D. (2003) · Human Genetics · doi:10.1007/s00439-002-0860-x · Cited by 89
Interleukin-1 gene expression in rabbit vascular tissue in vivo.
Clinton, S. K., Fleet, J. C., Loppnow, H., Salomon, R., Clark, B. D., Cannon, J. G., SHAW, A. R., Dinarello, C. A., & Libby, P. (1991) · PubMed · Cited by 87
Self-citationFormation of the inflammasome in acute myocarditis
Toldo, S. A., Kannan, H. R., Bussani, R., Anzini, M., Sonnino, C., Sinagra, G., Merlo, M., Mezzaroma, E., De‐Giorgio, F., Silvestri, F., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.12.137 · Cited by 87
Self-citationAbbate, A., Salloum, F. N., Tassell, B. W. V., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027923 · Cited by 86
Self-citationToldo, S. A., Mezzaroma, E., Bressi, E., Marchetti, C., Carbone, S., Sonnino, C., Tassell, B. W. V., & Abbate, A. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000106 · Cited by 86
Self-citationTassell, B. W. V., Varma, A., Salloum, F. N., Das, A., Seropian, I. M., Toldo, S. A., Smithson, L. A., Hoke, N. N., Chau, V. Q., Robati, R., et al. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181c87e53 · Cited by 84
Self-citationIndependent roles of the priming and the triggering of the NLRP3 inflammasome in the heart
Toldo, S. A., Mezzaroma, E., McGeough, M. D., Peña, C. A., Marchetti, C., Sonnino, C., Tassell, B. W. V., Salloum, F. N., Voelkel, N. F., Hoffman, H. M., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu259 · Cited by 83
Self-citationLim, B., Choe, S.-C., Shin, J.-O., Ho, S., Kim, J., Yu, S., Kim, S., & Jeon, E. (2002) · Circulation · doi:10.1161/circ.105.11.1278 · Cited by 79
Bone marrow‐specific caspase‐1/11 deficiency inhibits atherosclerosis development in Ldlr−/− mice
Hendrikx, T., Jeurissen, M. L. J., van Gorp, P. J., Gijbels, M. J., Walenbergh, S. M. A., Houben, T., van Gorp, R. H., Pöttgens, C. C. H., Stienstra, R., Netea, M. G., et al. (2015) · FEBS Journal · doi:10.1111/febs.13279 · Cited by 77
Gorelik, M., Lee, Y., Abe, M., Andrews, T., Davis, L., Patterson, J., Chen, S., Crother, T. R., Aune, G. J., Rivas, M. N., et al. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13314 · Cited by 76
Interleukin-1 blockade for the treatment of pericarditis
Buckley, L. F., Viscusi, M. M., Tassell, B. W. V., & Abbate, A. (2017) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvx018 · Cited by 69
Self-citationNlrp3 plays no role in acute cardiac infarction due to low cardiac expression
Jong, W. M. C., Leemans, J. C., Weber, N. C., Juffermans, N. P., Schultz, M. J., Hollmann, M. W., & Zuurbier, C. J. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.09.148 · Cited by 59
Ji, Q., Meng, K., Yu, K., Huang, S. L., Huang, Y., Min, X., Zhong, Y., Wu, B., Liu, Y., Nie, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02987-4 · Cited by 59
Chai, M., Ji, Q., Zhang, H., Zhou, Y., Yang, Q., Yangwei, Z., Guo, G., Liu, W., Han, W., 杨丽霞, et al. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0212 · Cited by 53
Tassell, B. W. V., Lipinski, M. J., Appleton, D. L., Roberts, C. S., Kontos, M. C., Abouzaki, N. A., Melchior, R. D., Mueller, G. H., Garnett, J., Canada, J. M., et al. (2018) · Clinical Cardiology · doi:10.1002/clc.22988 · Cited by 53
Self-citationPrimary and Secondary Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction
Buono, M. G. D., Buckley, L. F., & Abbate, A. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.07.012 · Cited by 52
Self-citationInterleukin‐38 alleviates cardiac remodelling after myocardial infarction
Wei, Y., Lan, Y., Zhong, Y., Yu, K., Xu, W., Zhu, R., Sun, H., Ding, Y., Wang, Y., & Zeng, Q. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14741 · Cited by 49
Reduction of Myocardial Ischemia–Reperfusion Injury by Inhibiting Interleukin-1 Alpha
Mauro, A. G., Mezzaroma, E., Torrado, J., Kundur, P., Joshi, P., Stroud, K., Quaini, F., Lagrasta, C. A. M., Abbate, A., & Toldo, S. A. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000452 · Cited by 45
Self-citationToldo, S. A., Schatz, A., Mezzaroma, E., Chawla, R., Stallard, T. W., Stallard, W. C., Jahangiri, A., Tassell, B. W. V., & Abbate, A. (2012) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6389-x · Cited by 44
Self-citationThe effect of colchicine on pyrin and pyrin interacting proteins
Taşkıran, E. Z., Çetinkaya, A., Balcı‐Peynircioğlu, B., Akkaya‐Ulum, Y. Z., & Yılmaz, E. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24231 · Cited by 44
Transgenic Overexpression of IL-37 Protects Against Atherosclerosis and Strengthens Plaque Stability
Liu, J., Lin, J., He, S., Chun, W., Wang, B., Liu, J., Duan, Y., Liu, T., Shan, S., Yang, K., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000487344 · Cited by 43
Interleukin-1 Blockade in Cardiovascular Diseases: From Bench to Bedside
Buckley, L. F., & Abbate, A. (2018) · BioDrugs · doi:10.1007/s40259-018-0274-5 · Cited by 38
Self-citationDevelopment of covalent NLRP3 inflammasome inhibitors: Chemistry and biological activity
Bertinaria, M., Gastaldi, S., Marini, E., & Giorgis, M. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.11.013 · Cited by 38
Schofer, N., Ludwig, S., Rübsamen, N., Schnabel, R. B., Lackner, K. J., Ruprecht, H. J., Bickel, C., Landmesser, U., Blankenberg, S., & Zeller, T. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.01.055 · Cited by 35
Noè, A., Howard, C. P., Thuren, T. Y., Taylor, A. E., & Skerjanec, A. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.08.004 · Cited by 34
Inflammasome Formation in Granulomas in Cardiac Sarcoidosis
Kron, J., Mauro, A. G., Bonaventura, A., Toldo, S. A., Salloum, F. N., Ellenbogen, K. A., & Abbate, A. (2019) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.007582 · Cited by 32
Self-citationThe NLRP3 Inflammasome as a Pharmacological Target
Marchetti, C. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000718 · Cited by 31
Self-citationBuckley, L. F., & Libby, P. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000701 · Cited by 31
Khanna, V., Jain, M. K., Singh, V., Kanshana, J. S., Prakash, P., Barthwal, M. K., Murthy, P. S. R., & Dikshit, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077037 · Cited by 27
Somma, S. D., Pittoni, V., Raffa, S., Magrini, L., Gagliano, G., Marino, R., Nobili, V., & Torrisi, M. R. (2013) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872613499282 · Cited by 24
Intracellular Function of Interleukin-1 Receptor Antagonist in Ischemic Cardiomyocytes
Vecile, E., Dobrina, A., Salloum, F. N., Tassell, B. W. V., Falcione, A., Gustini, E., Secchiero, S., Crovella, S., Sinagra, G., Finato, N., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053265 · Cited by 21
Self-citationvan Wezenbeek, J., Canada, J. M., Ravindra, K., Carbone, S., Kadariya, D., Trankle, C. R., Wohlford, G. F., Buckley, L. F., Buono, M. G. D., Billingsley, H., et al. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.09.036 · Cited by 18
Self-citationAnakinra in Fulminant Myocarditis: Targeting Interleukin-1 and the Inflammasome Formation*
Noji, Y. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001769 · Cited by 15
Why the CANTOS Is a Game Changer in Cardiovascular Medicine
Abbate, A. (2017) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000546 · Cited by 14
Self-citation
Cited by
Targeting inflammation in atherosclerosis — from experimental insights to the clinic
Soehnlein, O., & Libby, P. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00198-1 · Cited by 1,019
Signaling pathways and targeted therapy for myocardial infarction
Zhang, Q., Wang, L., Wang, S., Cheng, H., Xu, L., Pei, G., Wang, Y., Fu, C., Jiang, Y., He, C., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00925-z · Cited by 831
COVID-19 infection: an overview on cytokine storm and related interventions
Montazersaheb, S., Hosseiniyan Khatibi, S. M., Hejazi, M. S., Tarhriz, V., Farjami, A., Ghasemian Sorbeni, F., Farahzadi, R., & Ghasemnejad, T. (2022) · Virology Journal · doi:10.1186/s12985-022-01814-1 · Cited by 610
A 360° view of the inflammasome: Mechanisms of activation, cell death, and diseases
Barnett, K. C., Li, S., Liang, K., & Ting, J. P.-Y. (2023) · Cell · doi:10.1016/j.cell.2023.04.025 · Cited by 458
Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure
Hanna, A., & Frangogiannis, N. G. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07071-0 · Cited by 418
Metadata
- Authors
- Abbate, A., Toldo, S., Marchetti, C., Kron, J., Van Tassell, B. W., & Dinarello, C. A.
- Venue
- Circulation Research
- Published
- 2020-04-24
- Volume
- 126
- Issue
- 9
- Pages
- 1260-1280
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W3020229374
- Cited by
- 730
- References
- 178
- FWCI
- 26.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.